Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

Don’t let the term ‘elective’ fool you, physicians urge the public

According to Becker’s Hospital Review, the…

EVIDENCIA CLÍNICA SYNOLIS VA®

CLÍNICA SYNOLIS VA® RENDIMIENTO  EN EL DOLOR Y…

6 de enero Día de la Enfermera

Felicidades a todas las enfermeras y enfermeros…

Comprendiendo la diabetes tipo 5: causas, características y a quiénes afecta

La Federación Internacional de Diabetes (FDI)…

COVID-19 cited in significant increase in healthcare-associated infections in 2020

According to ScienceDaily, a CDC analysis of…

New antibiotic packs a punch against bacterial resistance

Scientists at The Scripps Research Institute…

Ozempic: la moda de bajar de peso rápido, pero con graves riesgos para la salud

Lo que comenzó como una tendencia en Hollywood…

New treatment for drug-resistant bacterial infections

ScienceDaily has recently reported on a study by…